METHYL 2-(6-(TRIFLUOROMETHYL)PYRIDIN-2-YL)ACETATE, 95%, 5g

1-Boc-2-methyl-3-oxopiperazine, 95.0%, 500mg

Potassium hexachloroplatinate(IV), min. 99.9%, pa, 5 g, glass packaging

2-Propenamide, N-[3-[2-[[2,3-difluoro-4-[4-(2-hydroxyethyl)-1-piperazinyl]phenyl]amino]-8-quinazolinyl]phenyl]-, 25mg

(3-Bromo-4-methylphenyl)boronic acid, 98%, 5g

3-{[(7H-purin-6-yl)amino]methyl}phenol, 98%, 5g

2-butyl-6-hydroxy-1,4-dihydropyrimidin-4-one, 100mg

5-(tert-Butyl)nicotinic acid, 95.0%, 10g

3-(Toluene-4-sulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester, 500mg

ethyl 5-hydroxy-6-oxo-2,3-dihydro-1H-pyridine-4-carboxylate, 95+%, 250mg

1-Chloro-2-(1-trifluoromethyl-cyclopropyl)-benzene, 250mg

R-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid, 95.0%, 500g

L-asparagine monohydrate, min. 99%, Ph.Eur., for biochemistry, 100 g, plastic packaging.